The oncogenic function of TUBA1C was further validated by wound healing assays in two ccRCC cell lines, with the results revealing that the migratory ability of these cells was significantly reduced following the knockdown of TUBA1C. The gene discussed is TUBA1C; the disease is nonpapillary renal cell carcinoma.